Non-Sedating Anti-Itch Options

First-Line Non-Sedating Oral Antihistamines

• The British Association of Dermatologists recommends fexofenadine 180 mg once daily as a truly non-sedating option for generalized pruritus 1, 2
• The British Association of Dermatologists suggests loratadine 10 mg once daily as a non-sedating option with once-daily dosing 1, 3, 4
• The British Association of Dermatologists recommends cetirizine 10 mg once daily, classified as "mildly sedative" but generally well-tolerated for daytime use 1, 2

Dosing Strategy

• The British Journal of Dermatology guidelines suggest offering patients a choice of at least two different non-sedating antihistamines, as individual responses vary significantly 4
• The British Journal of Dermatology guidelines recommend starting with standard manufacturer-recommended doses and adjusting timing to ensure peak drug levels coincide with anticipated worst itch periods 4

Combination Therapy for Refractory Cases

• The British Association of Dermatologists recommends adding an H2 antagonist (cimetidine) to an H1 antihistamine (fexofenadine) for enhanced effect through dual receptor blockade 1, 2

Topical Non-Sedating Options

• The British Association of Dermatologists suggests menthol 1% in aqueous cream for its cooling antipruritic effect 1, 4
• The British Association of Dermatologists recommends topical clobetasone butyrate as a mild corticosteroid for the inflammatory component 1, 2

Alternative Non-Antihistamine Options

• The British Association of Dermatologists recommends gabapentin 100-300 mg three times daily, particularly effective for neuropathic itch and elderly patients 1, 2
• The British Association of Dermatologists suggests pregabalin as a GABA agonist for severe, constant pruritus 1, 3

Clinical Context Considerations

• The British Association of Dermatologists explicitly recommends against sedative antihistamines in elderly patients with pruritus due to cognitive impairment risk 1, 2
• The British Association of Dermatologists suggests non-sedating antihistamines are preferred for urticaria where histamine is the primary mediator 4

Important Caveats

• The British Association of Dermatologists notes that mizolastine is contraindicated with cardiac disease, QT prolongation, or concurrent use of CYP450 inhibitors (macrolides, azole antifungals) 4
• The British Association of Dermatologists recommends reserving sedating antihistamines (hydroxyzine) exclusively for nighttime use when sleep disruption is the primary concern 1, 2, 3